The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Cyclacel Pharmaceuticals, Inc(NASDAQ:CYCC) 
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase I clinical trial f...
Website: http://www.cyclacel.com
Founded: 1996
Full Time Employees: 12
Sector: Healthcare
Industry: Biotechnology
Cyclacel Pharmaceuticals Days Payable Outstanding ttm (DPO)
Cyclacel Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Cyclacel Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Cyclacel Pharmaceuticals Op Cashflow Per Share ttm
Cyclacel Pharmaceuticals Free Cashflow Per Share ttm
Cyclacel Pharmaceuticals Cash Per Share ttm
Cyclacel Pharmaceuticals P/S ratio ttm
Cyclacel Pharmaceuticals (GAAP) P/E ratio ttm
Cyclacel Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.